ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
@ The comorbidity, co-prescribing, and co-occurrence of disability among persons with chronic pain create greater challenges in managing each condition and reducing impact. Pain cannot be managed in isolation. (Wallace, […]
Registration for the 30th Napa Pain Conference is now open!
